Integration of single-cell RNA-seq data into population models to characterize cancer metabolism.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
02 2019
Historique:
received: 20 06 2018
accepted: 22 12 2018
revised: 12 03 2019
pubmed: 1 3 2019
medline: 29 3 2019
entrez: 1 3 2019
Statut: epublish

Résumé

Metabolic reprogramming is a general feature of cancer cells. Regrettably, the comprehensive quantification of metabolites in biological specimens does not promptly translate into knowledge on the utilization of metabolic pathways. By estimating fluxes across metabolic pathways, computational models hold the promise to bridge this gap between data and biological functionality. These models currently portray the average behavior of cell populations however, masking the inherent heterogeneity that is part and parcel of tumorigenesis as much as drug resistance. To remove this limitation, we propose single-cell Flux Balance Analysis (scFBA) as a computational framework to translate single-cell transcriptomes into single-cell fluxomes. We show that the integration of single-cell RNA-seq profiles of cells derived from lung adenocarcinoma and breast cancer patients into a multi-scale stoichiometric model of a cancer cell population: significantly 1) reduces the space of feasible single-cell fluxomes; 2) allows to identify clusters of cells with different growth rates within the population; 3) points out the possible metabolic interactions among cells via exchange of metabolites. The scFBA suite of MATLAB functions is available at https://github.com/BIMIB-DISCo/scFBA, as well as the case study datasets.

Identifiants

pubmed: 30818329
doi: 10.1371/journal.pcbi.1006733
pii: PCOMPBIOL-D-18-01038
pmc: PMC6413955
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1006733

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Nat Biotechnol. 2001 Feb;19(2):125-30
pubmed: 11175725
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13134-9
pubmed: 14578455
Metab Eng. 2003 Oct;5(4):264-76
pubmed: 14642354
Nat Rev Microbiol. 2004 Nov;2(11):886-97
pubmed: 15494745
Mol Syst Biol. 2007;3:119
pubmed: 17625511
J Natl Cancer Inst. 2007 Oct 3;99(19):1441-54
pubmed: 17895480
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
pubmed: 18032601
PLoS Comput Biol. 2008 May 16;4(5):e1000082
pubmed: 18483554
Nat Biotechnol. 2008 Sep;26(9):1003-10
pubmed: 18711341
Proc Natl Acad Sci U S A. 2009 Apr 21;106(16):6477-82
pubmed: 19346491
PLoS Comput Biol. 2009 Aug;5(8):e1000489
pubmed: 19714220
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
Nat Biotechnol. 2010 Mar;28(3):245-8
pubmed: 20212490
Sci Signal. 2010 Apr 27;3(119):ra31
pubmed: 20424262
Sci Signal. 2010 Jun 01;3(124):pe19
pubmed: 20516476
Bioinformatics. 2010 Dec 15;26(24):3140-2
pubmed: 21081510
Nat Biotechnol. 2010 Dec;28(12):1279-85
pubmed: 21102456
Bioinformatics. 2011 Feb 15;27(4):541-7
pubmed: 21172910
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
IET Syst Biol. 2011 Mar;5(2):137-44
pubmed: 21405202
Cell Cycle. 2011 Jun 1;10(11):1772-83
pubmed: 21558814
Cell Cycle. 2011 Aug 1;10(15):2504-20
pubmed: 21778829
Nat Rev Drug Discov. 2011 Aug 31;10(9):671-84
pubmed: 21878982
Nat Protoc. 2011 Aug 04;6(9):1290-307
pubmed: 21886097
Cancer Cell. 2012 Mar 20;21(3):297-308
pubmed: 22439925
PLoS One. 2012;7(5):e36947
pubmed: 22606312
PLoS Comput Biol. 2012;8(5):e1002518
pubmed: 22615553
BMC Syst Biol. 2012 Jun 19;6:73
pubmed: 22713172
Cancer Biol Ther. 2012 Oct;13(12):1185-94
pubmed: 22892846
Front Physiol. 2012 Aug 06;3:299
pubmed: 22934050
Cancer Discov. 2012 Oct;2(10):881-98
pubmed: 23009760
PLoS Comput Biol. 2012;8(9):e1002688
pubmed: 23028286
BMC Syst Biol. 2012 Dec 06;6:150
pubmed: 23216785
BMC Syst Biol. 2012 Dec 13;6:153
pubmed: 23234303
PLoS One. 2013 May 31;8(5):e64567
pubmed: 23741341
Nature. 2013 Sep 19;501(7467):346-54
pubmed: 24048067
Nat Rev Cancer. 2013 Oct;13(10):727-38
pubmed: 24060864
Science. 2013 Dec 6;342(6163):1243259
pubmed: 24311695
Science. 2014 Feb 28;343(6174):1245114
pubmed: 24436182
Cancer Immunol Res. 2013 Oct;1(4):245-55
pubmed: 24455753
BMC Cancer. 2014 Mar 05;14:154
pubmed: 24597899
PLoS Comput Biol. 2014 Apr 24;10(4):e1003580
pubmed: 24762745
Metabolites. 2013 Oct 14;3(4):946-66
pubmed: 24958259
PLoS One. 2014 Sep 12;9(9):e106913
pubmed: 25215509
Front Plant Sci. 2014 Sep 19;5:491
pubmed: 25285097
Nat Rev Genet. 2015 Mar;16(3):133-45
pubmed: 25628217
Sci Rep. 2015 Feb 11;5:8380
pubmed: 25670024
Science. 2015 Mar 6;347(6226):1066-7
pubmed: 25745146
Cancer Res. 2015 Apr 15;75(8):1567-79
pubmed: 25878146
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Genome Biol. 2015 Jun 19;16:127
pubmed: 26084335
Mol Syst Biol. 2015 Jun 30;11(6):817
pubmed: 26130389
Biochim Biophys Acta. 2015 Dec;1853(12):3211-23
pubmed: 26384873
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
Front Mol Biosci. 2016 Feb 10;3:3
pubmed: 26904548
PLoS Comput Biol. 2016 Mar 04;12(3):e1004808
pubmed: 26942765
Comput Biol Chem. 2016 Jun;62:60-9
pubmed: 27085310
Cell. 2016 Apr 21;165(3):535-50
pubmed: 27104977
Metabolomics. 2016;12:109
pubmed: 27358602
Front Genet. 2016 Sep 21;7:163
pubmed: 27708664
Nature. 2016 Nov 30;540(7631):153-155
pubmed: 27905420
Curr Opin Chem Biol. 2017 Feb;36:15-23
pubmed: 28064089
Cell Syst. 2017 Mar 22;4(3):318-329.e6
pubmed: 28215528
Nat Commun. 2017 May 05;8:15081
pubmed: 28474673
Bioinformatics. 2017 Jul 15;33(14):i311-i318
pubmed: 28881985
PLoS Comput Biol. 2017 Sep 28;13(9):e1005758
pubmed: 28957320
Nat Biotechnol. 2018 Mar;36(3):272-281
pubmed: 29457794
J Biomed Inform. 2018 Nov;87:37-49
pubmed: 30244122

Auteurs

Chiara Damiani (C)

Dept. of Informatics, Systems and Communication, University of Milan-Bicocca, 20126, Milan, Italy.
SYSBIO Centre of Systems Biology, 20126, Milan, Italy.

Davide Maspero (D)

Dept. of Biotechnology and Biosciences, University of Milan-Bicocca, 20126, Milan, Italy.
Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Marzia Di Filippo (M)

SYSBIO Centre of Systems Biology, 20126, Milan, Italy.
Dept. of Biotechnology and Biosciences, University of Milan-Bicocca, 20126, Milan, Italy.

Riccardo Colombo (R)

Dept. of Informatics, Systems and Communication, University of Milan-Bicocca, 20126, Milan, Italy.
SYSBIO Centre of Systems Biology, 20126, Milan, Italy.

Dario Pescini (D)

SYSBIO Centre of Systems Biology, 20126, Milan, Italy.
Dept. of Statistics and Quantitative Methods, University of Milan-Bicocca, 20126, Milan, Italy.

Alex Graudenzi (A)

Dept. of Informatics, Systems and Communication, University of Milan-Bicocca, 20126, Milan, Italy.

Hans Victor Westerhoff (HV)

Dept. of Molecular Cell Physiology, Faculty of Earth and Life Sciences, VU University, Amsterdam, The Netherlands.
Manchester Centre for Integrative Systems Biology, School of Chemical Engineering and Analytical Science, University of Manchester, Manchester, United Kingdom.
Swammerdam Institute for Life Sciences, Faculty of Science, University of Amsterdam, Amsterdam, The Netherlands.

Lilia Alberghina (L)

SYSBIO Centre of Systems Biology, 20126, Milan, Italy.
Dept. of Biotechnology and Biosciences, University of Milan-Bicocca, 20126, Milan, Italy.

Marco Vanoni (M)

SYSBIO Centre of Systems Biology, 20126, Milan, Italy.
Dept. of Biotechnology and Biosciences, University of Milan-Bicocca, 20126, Milan, Italy.

Giancarlo Mauri (G)

Dept. of Informatics, Systems and Communication, University of Milan-Bicocca, 20126, Milan, Italy.
SYSBIO Centre of Systems Biology, 20126, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH